Insider Transactions in Q3 2019 at Medtronic PLC (MDT)
Insider Transaction List (Q3 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2019
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
21,425
-10.7%
|
$2,292,475
$107.86 P/Share
|
|
Sep 25
2019
|
James T Lenehan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
744
-1.34%
|
$79,608
$107.62 P/Share
|
|
Sep 25
2019
|
James T Lenehan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,813
+3.17%
|
$79,772
$44.13 P/Share
|
|
Sep 10
2019
|
Hooman Hakami EVP & Group President Diabetes |
SELL
Open market or private sale
|
Direct |
82,877
-19.25%
|
$8,867,839
$107.26 P/Share
|
|
Sep 10
2019
|
Hooman Hakami EVP & Group President Diabetes |
BUY
Exercise of conversion of derivative security
|
Direct |
72,877
+13.8%
|
$6,121,668
$84.78 P/Share
|
|
Aug 05
2019
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Open market or private sale
|
Direct |
4,000
-7.03%
|
$400,000
$100.31 P/Share
|
|
Aug 02
2019
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
5,719
-5.4%
|
$583,338
$102.02 P/Share
|
|
Aug 02
2019
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Open market or private sale
|
Direct |
6,599
-10.39%
|
$673,098
$102.02 P/Share
|
|
Aug 01
2019
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
SELL
Payment of exercise price or tax liability
|
Direct |
29,689
-7.0%
|
$3,028,278
$102.37 P/Share
|
|
Aug 01
2019
|
Hooman Hakami EVP & Group President Diabetes |
SELL
Payment of exercise price or tax liability
|
Direct |
10,265
-10.61%
|
$1,047,030
$102.37 P/Share
|
|
Aug 01
2019
|
Omar Ishrak Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
24,894
-3.99%
|
$2,539,188
$102.37 P/Share
|
|
Aug 01
2019
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Payment of exercise price or tax liability
|
Direct |
4,795
-4.33%
|
$489,090
$102.37 P/Share
|
|
Aug 01
2019
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
5,533
-8.01%
|
$564,366
$102.37 P/Share
|
|
Aug 01
2019
|
John R Liddicoat EVP & President of Americas |
SELL
Payment of exercise price or tax liability
|
Direct |
9,942
-10.43%
|
$1,014,084
$102.37 P/Share
|
|
Aug 01
2019
|
Geoffrey Martha Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,775
-8.29%
|
$997,050
$102.37 P/Share
|
|
Aug 01
2019
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,533
-6.09%
|
$564,366
$102.37 P/Share
|
|
Aug 01
2019
|
Carol A Surface EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,058
-9.71%
|
$413,916
$102.37 P/Share
|
|
Aug 01
2019
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Payment of exercise price or tax liability
|
Direct |
8,087
-6.13%
|
$824,874
$102.37 P/Share
|
|
Aug 01
2019
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
8,182
-7.03%
|
$834,564
$102.37 P/Share
|
|
Jul 29
2019
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
BUY
Grant, award, or other acquisition
|
Direct |
14,850
+6.39%
|
-
|
|
Jul 29
2019
|
Hooman Hakami EVP & Group President Diabetes |
BUY
Grant, award, or other acquisition
|
Direct |
8,071
+13.66%
|
-
|
|
Jul 29
2019
|
Omar Ishrak Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
45,194
+6.76%
|
-
|
|
Jul 29
2019
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Grant, award, or other acquisition
|
Direct |
10,330
+8.53%
|
-
|
|
Jul 29
2019
|
Bradley E Lerman SVP General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
10,330
+13.02%
|
-
|
|
Jul 29
2019
|
John R Liddicoat EVP & President of Americas |
BUY
Grant, award, or other acquisition
|
Direct |
6,134
+11.11%
|
-
|
|
Jul 29
2019
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,267
+16.65%
|
-
|
|
Jul 29
2019
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,204
+13.51%
|
-
|
|
Jul 29
2019
|
Carol A Surface EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,425
+15.09%
|
-
|
|
Jul 29
2019
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Grant, award, or other acquisition
|
Direct |
9,039
+11.73%
|
-
|
|
Jul 29
2019
|
Robert John White EVP & Pres. Medical Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
11,622
+16.2%
|
-
|
|
Jul 22
2019
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
3,438
-3.32%
|
$347,238
$101.12 P/Share
|